Clinical trials: Female Sexual Arousal Disorder

Sexual Dysfunctions, Psychological

Study of Pharmacological Treatment in Women With Female Sexual Interest/Arousal Disorder (FSIAD).

• Unknown status
• Age: 18 to 65 years
• Phase 3
• Pill or oral medicine

This clinical trial is a prospective, randomized, double-blind Phase III study with two arms to determine the efficacy and safety of the use of an IPDE in women with FSIAD.

Trial name

FSIAD (NCT04433559)

Testing

Tadalafil 1,5 mg oral tablets

Volunteers

80 people

Sponsor

Lidia Larrañaga